
The maker of Androgel will face a series of trials after its most recent court loss.

The maker of Androgel will face a series of trials after its most recent court loss.

Sometimes customers are people too.

A new study shows that a pharmacist-physician team can lower inappropriate drug use.

The chain is accused of not reporting opioid thefts by its employees.

Pharmacy never changes in the final part of our “Best of the 70s” series.

A new study shows that only a third of children suffering allergic reactions receive epinephrine immediately.

The FDA has already approved 24 new drugs in 2017. Here's what you need to know about the latest 5.

The drugs might change, but the people never do. Part 2 of our best of the 70s series.

An investigation into Actemra (tocilizumab) has uncovered hundreds of serious adverse drug events, but the drug's labeling has not been changed.

A new study looks at how pharmacists can prevent medication-related admissions.

From a 1970s column, “silly syndrome,” the best customer stories of the decade.

The agency is trying to deliver on its goal of a 90-day response time.

A new BCBS study finds that 21% of insured members filled at least one opioid script in 2015.

After anti-trust woes, the acquisition is thrown out and Walgreens buys over 2,000 stores.

The owner of Indiana-based Pharmakon Pharmaceuticals is charged with distributing adulterated drugs and lying to the FDA.

The NECC tragedy comes to a close as Barry Cadden is sentenced.

Why some red yeast rice supplements could be considered prescription drugs.

Easy-to-swallow bits of news from around the world of pharmacy.

Two groups join up to help the Massachusetts State Office of Pharmacy Services.

Younger people, females, black or Hispanic less likely to have medication.


So just how much naloxone is getting out? How many pharmacies EPCS enabled?

The recall is a major setback in the ongoing sodium bicarbonate shortage.

A new study shows how the Medicare donut hole could be costing patients.

As the opioid crisis worsens, debates rage about the best methods to combat it.

The U.S. market remains the largest single-country market in the world.

A study found that pharmacy practice faculty experience high rates of emotional exhaustion.

With the threat of superbugs and the possibility of an antibiotic-less future, alternatives are needed now.

Reimbursement, initiation, and what pharmacists can do.

The PBM giant claims it is owed $14.5 million in fees.